Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis.

Saldanha IJ, Akinyede O, Robinson KA.

Cochrane Database Syst Rev. 2018 Jun 18;6:CD009421. doi: 10.1002/14651858.CD009421.pub4. Review.

PMID:
29921013
2.

Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.

Green J, Gilchrist FJ, Carroll W.

Cochrane Database Syst Rev. 2018 Jun 12;6:CD012619. doi: 10.1002/14651858.CD012619.pub2. Review.

PMID:
29894558
3.

Respiratory muscle training for cystic fibrosis.

Hilton N, Solis-Moya A.

Cochrane Database Syst Rev. 2018 May 24;5:CD006112. doi: 10.1002/14651858.CD006112.pub4. Review.

PMID:
29797578
4.

Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

Jat KR, Walia DK, Khairwa A.

Cochrane Database Syst Rev. 2018 Mar 18;3:CD010288. doi: 10.1002/14651858.CD010288.pub4. Review.

PMID:
29551015
5.

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Hussein N, Weng SF, Kai J, Kleijnen J, Qureshi N.

Cochrane Database Syst Rev. 2018 Mar 14;3:CD010849. doi: 10.1002/14651858.CD010849.pub3. Review.

PMID:
29537064
6.

Prognostic significance of pulmonary hypertension in patients with cystic fibrosis: A systematic review and meta-analysis.

Li D, Wang B, Wang H, Liu Q.

Medicine (Baltimore). 2018 Feb;97(7):e9708. doi: 10.1097/MD.0000000000009708. Review.

7.

Inhaled mannitol for cystic fibrosis.

Nevitt SJ, Thornton J, Murray CS, Dwyer T.

Cochrane Database Syst Rev. 2018 Feb 9;2:CD008649. doi: 10.1002/14651858.CD008649.pub3. Review.

PMID:
29424930
8.

Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations.

Hadjiliadis D, Khoruts A, Zauber AG, Hempstead SE, Maisonneuve P, Lowenfels AB; Cystic Fibrosis Colorectal Cancer Screening Task Force.

Gastroenterology. 2018 Feb;154(3):736-745.e14. doi: 10.1053/j.gastro.2017.12.012. Epub 2017 Dec 29.

PMID:
29289528
9.

Pharmacological management of cystic fibrosis related diabetes.

Moheet A, Moran A.

Expert Rev Clin Pharmacol. 2018 Feb;11(2):185-191. doi: 10.1080/17512433.2018.1421065. Epub 2018 Jan 5. Review.

PMID:
29268054
10.

Long-acting inhaled bronchodilators for cystic fibrosis.

Smith S, Edwards CT.

Cochrane Database Syst Rev. 2017 Dec 19;12:CD012102. doi: 10.1002/14651858.CD012102.pub2. Review.

PMID:
29253920
11.

Oral cavity health among cystic fibrosis patients: Literature overview.

Herman K, Kowalczyk-ZajÄ…c M, Pytrus T.

Adv Clin Exp Med. 2017 Oct;26(7):1147-1153. doi: 10.17219/acem/64054. Review.

12.

Atomic Force Microscopy: A Promising Tool for Deciphering the Pathogenic Mechanisms of Fungi in Cystic Fibrosis.

Cuenot S, Bouchara JP.

Mycopathologia. 2018 Feb;183(1):291-310. doi: 10.1007/s11046-017-0201-1. Epub 2017 Nov 11. Review.

PMID:
29128932
13.

Improving transition to adult healthcare for young people with cystic fibrosis: A systematic review.

Coyne I, Sheehan AM, Heery E, While AE.

J Child Health Care. 2017 Sep;21(3):312-330. doi: 10.1177/1367493517712479. Epub 2017 Jun 6. Review.

PMID:
29119815
14.

Genetic therapies for cystic fibrosis lung disease.

Hart SL, Harrison PT.

Curr Opin Pharmacol. 2017 Jun;34:119-124. doi: 10.1016/j.coph.2017.10.006. Epub 2017 Nov 5. Review.

PMID:
29107808
15.

The implications of CFTR structural studies for cystic fibrosis drug development.

Callebaut I, Hoffmann B, Mornon JP.

Curr Opin Pharmacol. 2017 Jun;34:112-118. doi: 10.1016/j.coph.2017.09.006. Epub 2017 Nov 5. Review.

PMID:
29096277
16.

Physical exercise training for cystic fibrosis.

Radtke T, Nevitt SJ, Hebestreit H, Kriemler S.

Cochrane Database Syst Rev. 2017 Nov 1;11:CD002768. doi: 10.1002/14651858.CD002768.pub4. Review.

PMID:
29090734
17.

Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.

Wijers CD, Chmiel JF, Gaston BM.

Chron Respir Dis. 2017 Nov;14(4):392-406. doi: 10.1177/1479972317694621. Epub 2017 Mar 6. Review.

18.

Diagnosis and management of cystic fibrosis: summary of NICE guidance.

Villanueva G, Marceniuk G, Murphy MS, Walshaw M, Cosulich R; Guideline Committee.

BMJ. 2017 Oct 26;359:j4574. doi: 10.1136/bmj.j4574. Review. No abstract available.

PMID:
29074599
19.

Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport.

Li H, Salomon JJ, Sheppard DN, Mall MA, Galietta LJ.

Curr Opin Pharmacol. 2017 Jun;34:91-97. doi: 10.1016/j.coph.2017.10.002. Epub 2017 Oct 21. Review.

PMID:
29065356
20.

Correcting CFTR folding defects by small-molecule correctors to cure cystic fibrosis.

Mijnders M, Kleizen B, Braakman I.

Curr Opin Pharmacol. 2017 Jun;34:83-90. doi: 10.1016/j.coph.2017.09.014. Epub 2017 Oct 18. Review.

Supplemental Content

Loading ...
Support Center